For example, in patient #1, we found that only a fraction of the cancer cells in vivo had SMAD4 deletions, but essentially all tumor tissue-derived organoid cells from this patient had SMAD4 deletions which were further verified by Sanger sequencing (Additional file 1: Fig. S7C). Here, SMAD4 is linked to neoplasm.